| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | HKEX Exchange | G3961J102 CUSIP |
| China Country | 874 Employees | 16 Jun 2026 Last Dividend | - Last Split | - IPO Date |
Golden Throat Holdings Group Company Limited, established in 1956 and based in Liuzhou, the People's Republic of China, operates as an investment holding corporation focused on the production and sale of pharmaceutical, healthcare food, and various other products. This organization not only serves the domestic market but also exports its offerings to numerous international destinations including the United States, Canada, Japan, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and Africa. Golden Throat Holdings is renowned for its dedication to improving throat health and overall well-being through its extensive range of products.
Golden Throat Lozenges: These are over-the-counter medicines designed to alleviate sore throats, dryness, and hoarseness, typically caused by acute pharyngitis. Recognized for their effectiveness, these lozenges have garnered popularity as a reliable remedy.
Golden Throat Lozenge Series Products: This range includes:
Yinxingye Tablets: These tablets are formulated to facilitate blood circulation, remove blood stasis, and dredge energy channels. They are another testament to the company's commitment to offering health solutions that go beyond throat care.
Golden Throat Intestinal Series: Expanding its healthcare range, Golden Throat provides products specifically designed to support intestinal health, further broadening its contributions to the overall wellness of its customers.
Golden Throat Compound Probiotic Lozenges: A blend of probiotics and traditional throat lozenge benefits, these products aim to not only soothe the throat but also support digestive health, reflecting a holistic approach to wellness.